The ASCO Post, the #1 oncology newspaper, is a fundamental resource for busy clinicians who wish to stay informed about the rapidly changing field of oncology.
The ASCO Post, published by Harborside in partnership with the American Society of Clinical Oncology (ASCO), communicates news of evidence-based multidisciplinary cancer care to a broad audience of oncology professionals and ASCO members. It is the #1 oncology newspaper in the field (source: Kantar media).
Available in print and digital formats, The ASCO Post works to keep readers informed about the latest clinical oncology data. Under the guidance of James O. Armitage, MD, Editor-in-Chief, and a team of more than 40 editorial advisors from the United States and abroad, each issue features highly validated coverage of clinical cancer research and practice issues complemented by thoughtful commentary from leaders in the field of clinical oncology.
The ASCO Post also publishes The ASCO Post Evening News, a newsletter emailed to 21,550 U.S.-based and 11,000 international ASCO members nightly through the business week. It is a curated digest for health-care providers to quickly and accurately catch up on breaking news in the world of oncology.
The ASCO Post additionally produces The ASCO Post Newsreels, 2–3 minute video synopses of important research presented at major meetings.
The founding Editor-in-Chief of The ASCO Post, Dr. Armitage is The Joe Shapiro Professor of Medicine in the Division of Oncology & Hematology at the University of Nebraska Medical Center in Omaha. He is a former Dean of the College of Medicine and a past President of the American Society of Clinical Oncology (ASCO).
Dr. Armitage graduated from the University of Nebraska Medical Center in 1973 and completed his internship and residency in internal medicine there in 1975. In 1977, he completed a fellowship in hematology/oncology at the University of Iowa Hospitals and Clinics, Iowa City, Iowa.
Dr. Armitage is a Fellow of the American College of Physicians, the Royal College of Physicians, and ASCO. He has authored or co-authored over 500 articles, over 100 book chapters, and is the editor/co-editor of 27 books.View Editorial Board
The ASCO Post is the most-read oncology newspaper in the market. The current circulation for the publication is 28,000, and its frequency is 24 issues per year. Bonus distribution is available at over a dozen live medical conferences each year.
Advertising opportunities exist in print, for the website, for electronic table of contents emails, for The ASCO Post Evening News, and more. Further details are available in the media kit and rate card. Please contact our advertising representatives with any inquiries. All advertisements are subject to ASCO's Advertising Policy.